2. Von Dadelszen P., Payne B., Li J. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the full PIERS model. Lancet. 2011; 377(9761):219–227. Doi: 10.1016/S0140-6736(10)61351-7.

3. Mol B.W.J., Roberts C.T., Thangaratinam S., Magee L.A. Pre-eclampsia. Lancet. 2016; 387(10022):999–1011. Doi: 10.1016/S0140-6736(15)00070-7.

4. Vikse B.E., Irgens L.M., Leivestad T. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 2008;359(8):800–809. Doi: 10.1056/NEJMoa0706790.

5. Theilen L.H., Fraser A., Hollingshaus M.S. et al. All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol. 2016;128(2):238–244.

6. Piccoli G.B., Cabiddu G., Attini R. et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015;26(8):2011–2022. Doi: 10.1681/ASN.2014050459.

7. Zhang J.-J., Ma X.-X., Hao L., et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin. J. Am. Soc. Nephrol. 2015;10(11):1964–1978. Doi: 10.2215/CJN.09250914.

8. Alkhunaizi A., Melamed N., Hladunewich M.A. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 2015;24(3):252–259. Doi: 10.1097/MNH.0000000000000119.

9. Piccoli G.B., Cabiddu G., Castellino S., et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J. Nephrol. 2017;30(3):307–317. Doi: 10.1007/s40620-017-0390-1.

10. Liu Y., Ma X., Zheng J., Liu X., Yan T. Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2017;17(1):235. Doi: 10.1186/s12884-017-1402-9.

11. Jim B., Garovic V.D. Acute kidney injury in pregnancy. Semin. Nephrol. 2017;37(4):378–385. Doi: 10.1016/j.semnephrol.2017.05.010.

12. Acharya A. Management of acute kidney injury in pregnancy for the obstetrician. Obstet. Gynecol. Clin. North. Am. 2016;43(4):747–765. Doi: 10.1016/j.ogc.2016.07.007.

13. Iseki K. Gender differences in chronic kidney disease. Kidney International. 2008;74(4):415–417. Doi: 10.1038/ki.2008.261.

14. Nitsch D., Grams M., Sang Y., et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f324. Doi: 10.1136/bmj.f324.

15. Levin A., Djurdjev O., Beaulieu M., Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am. J. Kidney Dis. 2008;52(4):661–671. Doi: 10.1053/j.ajkd.2008.06.023.

16. Weiner D.E., Tighiouart H., Elsayed E.F., et al. The Framingham predictive instrument in chronic kidney disease. J. Am. Coll. Cardiol. 2007;50(3):217–224. Doi: 10.1016/j.jacc.2007.03.037.

17. Oladapo O.T., Adetoro O.O., Ekele B.A., et al. When getting there is not enough: a nationwide cross-sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country. BJOG. 2016;123(6):928–938. Doi:10.1111/1471-0528.13450.

18. Tranquilli A.L., Dekker G., Magee L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104. Doi:10.1016/j.preghy.2014.02.001.

19. Liu Y., Bao H., Jiang Z., et al. Pregnancy-related Acute kidney injury and a review of the literature in China. Intern. Med. 2015;54(14):1695–1703. Doi: 10.2169/internalmedicine.54.3870.

20. Prakash J., Pant P., Prakash S., et al. Changing picture of acute kidney injury in pregnancy: Study of 259 cases over a period of 33 years. Indian J. Nephrol. 2016;26(4):262–267. Doi: 10.4103/0971-4065.161018.

21. Ibarra-Hernández M., Orozco-Guillén O.A., de la Alcantar-Vallín M.L., et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from México. J. Nephrol. 2017;30(6):773–780. Doi: 10.1007/s40620-017-0444-4.

22. Blázquez A., García D., Rodríguez A., et al. Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. J. Assist. Reprod. Genet. 2016;33(7):855–863. Doi: 10.1007/s10815-016-0701-9.

23. O’Gorman N., Wright D., Poon L.C., et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet. Gynecol. 2017;49(6):756–760. Doi: 10.1002/uog.17455.

24. Zeisler H., Llurba E., Chantraine F., et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 2016;374(1):13-22. Doi: 10.1056/NEJMoa1414838.

25. Garovic V.D. The role of the podocyte in preeclampsia. Clin. J. Am. Soc. Nephrol. 2014;9(8):1337–1340. Doi: 10.2215/CJN.05940614.

26. Wide-Swensson D., Strevens H., Willner J. Antepartum percutaneous renal biopsy. Int. J. Gynaecol Obstet. 2007;98(2):88–92. Doi: 10.1016/j.ijgo.2007.03.049.

27. Shiiki H., Dohi K., Hanatani M., et al. Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome. Am. J. Nephrol. 1990;10(3):205–212. PMID: 2382682.

28. Linsell L., Malouf R., Morris J., et al. Risk factor models for neurodevelopmental outcomes in children born very preterm or with very low birth weight: a systematic review of methodology and reporting. Am. J. Epidemiol. 2017;185(7):601–612. Doi: 10.1093/aje/kww135.

29. Guellec I., Lapillonne A., Marret S., et al. Effect of intra- and extrauterine growth on long-term neurologic outcomes of very preterm Infants. J. Pediatr. 2016;175:93–99.e1. Doi: 10.1016/j.jpeds.2016.05.027.

30. Moore T., Hennessy E.M., Myles J., et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ. 2012;345:e7961. Doi: 10.1136/bmj.e7961.

31. Guillén Ú., DeMauro S., Ma L., et al. Relationship between attrition and Neurodevelopmental Impairment Rates in Extremely Preterm Infants at 18 to 24 Months: a systematic review. Arch. Pediatr. Adolesc. Med. 2012;166(2):178–184. Doi: 10.1001/archpediatrics.2011.616.

32. Ranke M.B., Schweizer R., Rodemann S.M., et al. Schoolchildren born VLBW or VLGA show height-related changes in body composition and muscle function but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study. J. Pediatr. Endocrinol. Metab. 2016;29(2):163–172. Doi: 10.1515/jpem-2015-0266.

33. Castanys‐Muñoz E., Kennedy K., Castañeda‐Gutiérrez E., et al. Systematic review indicates postnatal growth in term infants born small‐for‐gestational‐age being associated with later neurocognitive and metabolic outcomes. Acta. Paediatr. 2017;106(8):1230–1238. Doi: 10.1111/apa.13868.

34. Ong K.K., Kennedy K., Castañeda-Gutiérrez E., et al. Postnatal growth in preterm infants and later health outcomes: a systematic review. Acta. Paediatr. 2015;104(10):974–986. Doi: 10.1111/apa.13128.

35. Low birth weight and nephron number working group. The impact of kidney development on the life course: a consensus document for action. Nephron. 2017;136(1):3–49. Doi: 10.1159/000457967.

36. Luyckx V.A., Bertram J.F., Brenner B.M., et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet. 2013;382(9888):273–283. Doi: 10.1016/S0140-6736(13)60311-6.

37. Luyckx V.A., Brenner B.M. Birth weight, malnutrition and kidney-associated outcomes a global concern. Nat. Rev. Nephrol. 2015;11(3):135–149. Doi: 10.1038/nrneph.2014.251.

38. Davison J.M., Lindheimer M.D. Pregnancy and chronic kidney disease. Semin. Nephrol. 2011;31(1):86–99. Doi: 10.1016/j.semnephrol.2010.10.008.

39. Hall M. Pregnancy in women with CKD: a success story. Am. J. Kidney Dis. 2016;68(4):633–639. Doi: 10.1053/j.ajkd.2016.04.022.

40. Nevis I.F., Reitsma A., Dominic A. et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin. J. Am. Soc. Nephrol. 201;6(11):2587–2598. Doi: 10.2215/CJN.10841210.

41. Cabiddu G., Castellino S., Gernone G., et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 2016;29(3):277–303. Doi: 10.1007/s40620-016-0285-6.

42. Garg A.X., Nevis I.F., McArthur E., et al. Gestational hypertension and preeclampsia in living kidney donors. N. Engl. J. Med. 2015;372(2):124–133. Doi: 10.1056/NEJMoa1408932.

43. Josephson M.A. Transplantation: pregnancy after kidney donation: more questions than answers. Nat. Rev. Nephrol. 2009;5(9):495–497. Doi: 10.1038/nrneph.2009.129.

44. Gianfreda D., Quaglini S., Frontini G., et al. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J. Autoimmun. 2017;84:46–54. Doi: 10.1016/j.jaut.2017.06.003.

45. Blom K., Odutayo A., Bramham K., Hladunewich M.A. Pregnancy and glomerular disease: a systematic review of the literature with management guidelines. Сlin. J. Am. Soc. Nephrol. 2017;12(11):1862–1872. Doi: 10.2215/CJN.00130117.

46. Imbasciati E., Gregorini G., Cabiddu G., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney. Dis. 2007;49(6):753–762. Doi: 10.1053/j.ajkd.2007.03.022.

47. Fischer M.J. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv. Chronic. Kidney Dis. 2007;14(2):132–145. Doi: 10.1053/j.ackd.2007.01.004.

48. Bramham K. Diabetic nephropathy and pregnancy. Semin. Nephrol. 2017;37(4):362–369. Doi: 10.1016/j.semnephrol.2017.05.008.

49. Eswarappa M., Rakesh M., Sonika P., et al. Spectrum of renal injury in pregnancy-induced hypertension: Experience from a single center in India. Saudi Journal of Kidney Diseases and Transplantation. 2017;28(2):279. Doi: 10.4103/1319-2442.202790.

50. Prakash J. The kidney in pregnancy: A journey of three decades. Indian. J. Nephrol. 2012;22(3):159–167. Doi: 10.4103/0971-4065.98750.

51. Piccoli G.B., Fassio F., Attini R., et al. Pregnancy in CKD: whom should we follow and why? Nephrol. Dial. Transplant. 2012;27(3):iii111–118. Doi: 10.1093/ndt/gfs302.

52. Piccoli G.B., Cabiddu G., Daidone G., et al. The children of dialysis: live-born babies from on-dialysis mothers in Italy – an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol. Dial. Transplant. 2014;29(8):1578–1586. Doi: 10.1093/ndt/gfu092.

53. Jesudason S., Grace B.S., McDonald S.P. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin. J. Am. Soc. Nephrol. 2014;9(1):143–149. Doi: 10.2215/CJN.03560413.

54. Hladunewich M.A., Hou S., Odutayo A., et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J. Am. Soc. Nephrol. 2014;25(5):1103–1109. Doi:10.1681/ASN.2013080825.

55. Piccoli G.B., Minelli F., Versino E., et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol. Dial. Transplant. 2016;31(11):1915–1934. Doi: 10.1093/ndt/gfv395.

56. Deshpande N.A., James N.T., Kucirka L.M., et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am. J. Transplant. 2011;11(11):2388–2404. Doi: 10.1111/j.1600-6143.2011.03656.x.

57. Deshpande N.A., Coscia L.A., Gomez-Lobo V., et al. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev. Obstet. Gynecol. 2013;6(3–4):116–125. PMC4002187.

58. Bramham K., Nelson-Piercy C., Gao H., et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin. J. Am. Soc. Nephrol. 2013;8(2):290–298. Doi: 10.2215/CJN.06170612.

59. Piccoli G.B., Cabiddu G., Attini R., et al. Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis. Transplantation. 2017;101(10):2536–2544. Doi: 10.1097/TP.0000000000001649.

60. Webster P., Lightstone L., McKay D.B., Josephson M.A. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017; 91(5):1047–1056. Doi:10.1016/j.kint.2016.10.045.

61. Pietrzak B., Mazanowska N., Kociszewska-Najman B., et al. Successful pregnancy outcome after in vitro fertilization in a kidney graft recipient: a case report and literature review. Ann. Transplant. 2015;20:338–341. Doi: 10.12659/AOT.893735.

62. Norrman E., Bergh C., Wennerholm U-B. Pregnancy outcome and long-term follow-up after in vitro fertilization in women with renal transplantation. Hum. Reprod. 2015;30(1):205–213. Doi: 10.1093/humrep/deu293.

63. Tedeschi S.K., Bermas B., Costenbader K.H. Sexual disparities in the incidence and course of SLE and RA. Clin. Immunol. 2013;149(2):211–218. Doi: 10.1016/j.clim.2013.03.003.

64. Marder W., Vinet É., Somers E.C. Rheumatic autoimmune diseases in women and midlife health. Womens Midlife Health. 2015

65. Ortona E., Pierdominici M., Maselli A., et al. Sex-based differences in autoimmune diseases. Ann. Ist. Super Sanita. 2016;52(2):205–212. Doi: 10.4415/ANN_16_02_12.

66. Petri M. Epidemiology of systemic lupus erythematosus. Best. Pract. Res. Clin. Rheumatol. 2002;16(5):847–858. PMID: 12473278.

67. Weckerle C.E., Niewold T.B. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin. Rev. Allergy. Immunol. 2011;40(1):42–49. Doi:10.1007/s12016-009-8192-4.

68. Scofield R.H., Bruner G.R., Namjou B., et al. Klinefelter’s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 2008;58(8):2511–2517. Doi: 10.1002/art.23701.

69. Pierdominici M., Ortona E. Estrogen impact on autoimmunity onset and progression: the paradigm of systemic lupus erythematosus. Int. Trends in Immun. 2013;1(2):24–34.

70. Maselli A., Conti F., Alessandri C., et al. Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus. Biol. Sex. Differ. 2016

71. Kim S.J., Schätzle S., Ahmed S.S., et al. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the TFH cell repertoire and contributes to lupus. Nat. Immunol. 2017;18(9):1016–1024. Doi: 10.1038/ni.3793.

72. Langefeld C.D., Ainsworth H.C., Cunninghame Graham D.S., et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:16021. Doi: 10.1038/ncomms16021.

73. Niewold T.B., Hua J., Lehman T.J.A., et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes. Immun. 2007;8(6):492–502. Doi: 10.1038/sj.gene.6364408.

74. Tower C., Mathen S., Crocker I., Bruce I.N. Regulatory T cells in systemic lupus erythematosus and pregnancy. Am. J. Reprod. Immunol. 2013;69(6):588–595. Doi: 10.1111/aji.12081.

75. Almaani S., Meara A., Rovin B.H. Update on lupus nephritis. CJASN. 2016;CJN.05780616. Doi: 10.2215/CJN.05780616.

76. Buyon J.P., Kim M.Y., Guerra M.M., et al. Kidney outcomes and risk factors for nephritis (Flare/De Novo) in a multiethnic cohort of pregnant patients with lupus. Clin. J. Am. Soc. Nephrol. 2017;12(6):940–946. Doi: 10.2215/CJN.11431116.

77. Yelin E., Yazdany J., Trupin L. Relationship between process of care and a subsequent increase in damage in systemic lupus erythematosus. Arthritis Care & Research. 2017;69(6):927–932. Doi: 10.1002/acr.22977.

78. Kaplowitz E.T., Ferguson S., Guerra M., et al. Socioeconomic status contributes to racial/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus. Arthritis Care Res. 2017;69(6):833–841. Doi: 10.1002/acr.23021.

79. Myasoedova E., Crowson C.S., Kremers H.M. et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheum. 2010;62(6):1576–1582. Doi: 10.1002/art.27425.

80. Goemaere S., Ackerman C., Goethals K., et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J. Rheumatol. 1990;17(12):1620–1622 PMID: 2084234.

81. De Man Y.A., Dolhain R.J., van de Geijn F.E., et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis. Rheum. 2008;59(9):1241–1248.

82. Icardi A., Araghi P., Ciabattoni M., et al. Kidney involvement in rheumatoid arthritis. Reumatismo. 2003;55(2):76–85. PMID: 12874640.

83. Anders H.-J., Vielhauer V. Renal comorbidity in patients with rheumatic diseases. Arthritis. Research & Therapy. 201;13:222. Doi: 10.1186/ar3256.

84. Chiu H.-Y., Huang H.-L., Li C.-H., et al. Increased risk of chronic kidney disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study. PLOS ONE. 2015;10(9):e0136508. Doi: 10.1371/journal.pone.0153431.

85. Vinet É., Bernatsky S., Hudson M., et al. Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Research & Therapy. 2014;16:R130. Doi: 10.1186/ar4587.

86. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev. 2012;11(6–7):A430–436. Doi: 10.1016/j.autrev.2011.11.006.

87. Penn H., Denton C.P. Diagnosis, management and prevention of scleroderma renal disease. Curr. Opin. Rheumatol. 2008;20(6):692–696. Doi: 10.1097/BOR.0b013e3283108df7.

88. Anders H.J., Wiebecke B., Haedecke C., et al. MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am. J. Kidney Dis. 1999;33(4):e3. PMID:10196034.

89. Zakharova E.V., Makarova T.A., Stolyarevich E.S. ANCA-Associated Vasculitis in Patient with CREST-Syndrome – Case Report

90. Eckardt K-U., Coresh J., Devuyst O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–169. Doi: 10.1016/S0140-6736(13)60439-0.

91. Saran R., Robinson B., Abbott K.C. et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2017;69(3,1):A7–8. Doi: 10.1053/j.ajkd.2016.12.004.

92. Liyanage T., Ninomiya T., Jha V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. Doi: 10.1016/S0140-6736(14)61601-9.

93. Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans. Am. Clin. Climatol. Assoc. 2014;125:229–243; discussion 243–246.

94. WHO. Addressing gender within primary health care reforms. In: WHO editor. Gender, women and primary health care renewal: a discussion paper

95. Eguavoen A.N.T., Odiagbe S.O., Obetoh G.I. The status of women, sex preference, decision-making and fertility control in ekpoma community of Nigeria. J. Soc. Sci. 2007;15(1):43–49.

96. Halle M.P., Takongue C., Kengne A.P., et al. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrol. 2015;16:59. Doi: 10.1186/s12882-015-0044-2.

97. Ajayi S., Raji Y., Bello T., et al. Unaffordability of renal replacement therapy in Nigeria. Hong Kong Journal of Nephrology 2016;18:15–29.

98. Kausz A.T., Obrador G.T., Arora P., et al. Late initiation of dialysis among women and ethnic minorities in the United States. J. Am. Soc. Nephrol. 2000;11(12):2351–2357. PMID: 11095658.

99. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J. Am. Soc. Nephrol. 2005;16(1):180–188. Doi: 10.1681/ASN.2004070539.

100. Adams S.V., Rivara M., Streja E., et al. Sex differences in hospitalizations with maintenance hemodialysis. J. Am. Soc. Nephrol. 2017;28(9):2721–2728. Doi: 10.1681/ASN.2016090986.

101. Ethier J., Mendelssohn D.C., Elder S.J., et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2008;23(10):3219–3226. Doi: 10.1093/ndt/gfn261.

102. Depner T.A. Prescribing hemodialysis: the role of gender. Adv. Ren. Replace Ther. 2003;10(1):71–77. Doi: 10.1053/jarr.2003.50007.

103. Sehgal A.R. Outcomes of renal replacement therapy among blacks and women. Am. J. Kidney Dis. 2000;35(4):S148–152. PMID: 10766013.

104. Jindal R.M., Ryan J.J., Sajjad I., et al. Kidney transplantation and gender disparity. Am. J. Nephrol. 2005;25(5):474–483. Doi: 10.1159/000087920.

105. Couchoud C., Bayat S., Villar E., et al. REIN registry. A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation. 2012; 94(5):513–519.

106. Liu G., Li X., Liu T., et al. Gender disparity of living donor renal transplantation in East China. Clin. Transplant. 2013;27(1):98–103. Doi: 10.1111/ctr.12003.

107. Naghibi O., Naghibi M., Nazemian F. Gender disparity in kidney transplantation. Saudi. J. Kidney Dis. Transpl. 2008;19(4):545–550. PMID: 18580010.

108. Bal M.M., Saikia B. Gender bias in renal transplantation: are women alone donating kidneys in India? Transplant. Proc. 2007;39(10):2961–2963. Doi: 10.1016/j.transproceed.2007.08.089.

109. Hogan J, Couchoud C., Bonthuis M., et al. Gender disparities in access to pediatric renal transplantation in Europe: data from the ESPN/ERA-EDTA Registry. Am. J. Transplant. 2016;16(7):2097–2105. Doi: 10.1111/ajt.13723.

110. Gillespie A., Hammer H., Kolenikov S., et al. Sex differences and attitudes toward living donor kidney transplantation among urban black patients on hemodialysis. Clin. J. Am. Soc. Nephrol. 2014;9(10):1764–1772. Doi: 10.2215/CJN.12531213.

111. Salter M.L., McAdams-Demarco M.A., Law A., et al. Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. J. Am. Geriatr. Soc. 2014;62(5):843–849. Doi: 10.1111/jgs.12801.

112. Piccoli G.B., Attini R., Cabiddu G., et al. Maternal-fetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy? J. Autoimmun. 2017;79:91–98. Doi: 10.1016/j.jaut.2017.01.008.

113. Seeger H., Salfeld P., Eisel R., et al. Complicated pregnancies in inherited distal renal tubular acidosis: importance of acid-base balance. J. Nephrol. 2017;30(3):455–460. Doi: 10.1007/s40620-016-0370-x.

114. Yefet E., Tovbin D., Nachum Z. Pregnancy outcomes in patients with Alport syndrome. Arch. Gynecol. Obstet. 2016;293(4):739–747. Doi: 10.1007/s00404-015-3893-9.